Results 201 to 210 of about 2,347,356 (352)

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

A high selectivity and low detection limit carbon monoxide sensor based on Au-GO/Co-ZnO composite material. [PDF]

Microsyst Nanoeng
Zhou T, Chen T, Qi Z, Sun J, Niu Z, Li X, Ma T, Kong X, Zhao L, Lin J, Luo B, Li Z.   +11 more
europepmc   +1 more source

Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis. [PDF]

PLoS One, 2022
Amin AG, De P, Graham B, Jensen BL, Moreau E, Chatterjee D.   +5 more
europepmc   +1 more source

A Practical Approach to Determination of Laboratory GC-MS Limits of Detection*

, 1997
Paula J. Underwood, Gerald Kananen, E K Armitage   +2 more
openalex   +1 more source

Improved flow cytometric method to enumerate residual cells: Minimal linear detection limits for platelets, erythrocytes, and leukocytes [PDF]

, 2002
Josefa Pichler, Dieter Printz, D. Scharner, D. Trbojevic, J. Siekmann, G. Fritsch   +5 more
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Boosting the velocity detection limit of 3D single-cell tracking time-lapse MRI by balanced SSFP imaging. [PDF]

Magn Reson Med
Wilken E, Havlas A, Wachsmuth L, Masthoff M, Diwoky C, Faber C.   +5 more
europepmc   +1 more source

Real-Time Ellipsometric Surface Plasmon Resonance Sensor Using Polarization Camera May Provide the Ultimate Detection Limit. [PDF]

Biosensors (Basel), 2023
Vashistha N, Abuleil MJ, Shrivastav AM, Bajaj A, Abdulhalim I.   +4 more
europepmc   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

Unique Organic-Inorganic Hybrid Copper(I) Phosphate with Ultralow Ractopamine Detection Limit and In Situ Sensing Ability. [PDF]

Inorg Chem
Xie JF, Wei PC, Li Y, Chang CC, Chang KC, Lu CP, Hsu T, Tzou DM, Tu HL, Wang CM.   +9 more
europepmc   +1 more source